Doos L, Bradley E, Rushton CA, Satchithananda D, Davies SJ, Kadam UT. Heart failure and chronic obstructive pulmonary disease multimorbidity at hospital discharge transition: a study of patient and carer experience. Health Expectations. 2015; 18(6):2401-2412 103. Doughty RN, Wright SP, Pearl A, Walsh HJ, Muncaster S, Whalley GA et al. Randomized, controlled trial of integrated heart failure management: The Auckland Heart Failure Management Study. European Heart Journal. 2002; 23(2):139-46 104. Doukky R, Avery E, Mangla A, Collado FM, Ibrahim Z, Poulin MF et al. Impact of Dietary Sodium Restriction on Heart Failure Outcomes. JACC Heart Fail. 2016; 4(1):24-35 105. Driscoll A, Srivastava P, Toia D, Gibcus J, Hare DL. A nurse-led up-titration clinic improves chronic heart failure optimization of beta-adrenergic receptor blocking therapy a randomized controlled trial. BMC Research Notes. 2014; 7:668 106. Ducharme A, Doyon O, White M, Rouleau JL, Brophy JM. Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial. CMAJ: Canadian Medical Association 107. Duerden M, Tabberer M. A budget impact model for a drug in heart failure: Eplerenone. British Journal of Cardiology. 2008; 15(2):101-105 108. Edelmann F, Schmidt AG, Gelbrich G, Binder L, Herrmann-Lingen C, Halle M et al. Rationale and design of the 'aldosterone receptor blockade in diastolic heart failure' trial: a double- blind, randomized, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function in patients with symptomatic diastolic heart failure (Aldo-DHF). European Journal of Heart Failure. 2010; 12(8):874-82 109. Edelmann F, Wachter R, Schmidt AG, Kraigher-Krainer E, Colantonio C, Kamke W et al. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: The Aldo-DHF randomized controlled trial. JAMA. 2013; 110. 